Inhibrx Biosciences INBX
NASDAQ INBX
$90.61 -1.13 (-1.23%)
At close: Nov 10, 2026 · 4:00 PM EST

Inhibrx Biosciences (INBX) Market Capitalization (2024 - 2026)

Updated

Inhibrx Biosciences (INBX) recorded Market Capitalization of $1.39 billion in Q2 2026, up 574.7% from $206.57 million a year earlier.

Analysis

Inhibrx Biosciences (INBX) Market Capitalization (2024 - 2026) Analysis & Trends

For FY2025, Inhibrx Biosciences reported Market Capitalization of $1.15 billion, up 416.6% from FY2024.

  • Across earlier years, Market Capitalization came in at $222.93 million in FY2024.
  • The Q2 2026 figure is the highest quarterly Market Capitalization in data going back to Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Inhibrx Biosciences 1.45 Bn 882.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.39 Bn
Dec 31, 2025 1.15 Bn
Sep 30, 2025 488.30 Mn
Jun 30, 2025 206.57 Mn
Mar 31, 2025 202.52 Mn
Dec 31, 2024 222.93 Mn
Sep 30, 2024 226.69 Mn
Jun 30, 2024 205.12 Mn
API Access

Inhibrx Biosciences Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=INBX&period=max&api_key=YOUR_API_KEY